ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/SC-VC-PAB-MMAE
C68H105N11O17
1348.6 g/mol
Research Reagent

SC-VC-PAB-MMAE

CAS2259318-46-0
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

SC-VC-PAB-MMAE is a research reagent designed for use in antibody-drug conjugate (ADC) development. It consists of a monomethyl auristatin E (MMAE) payload linked to a cleavable valine-citrulline-p-aminobenzylcarbamate (VC-PAB) spacer and a maleimide functional group for conjugation to antibodies.

antibody-drug conjugate researchtargeted drug delivery studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing SC-VC-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.98

SuO-Glu-Val-Cit-PAB-MMAE

CAS1895916-24-1

antibody-drug conjugate linker payload

SimilarStructure SimilarSimilarity 0.81

VC-PAB-MMAE

CAS644981-35-1

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.78

MAL-di-EG-Val-Cit-PAB-MMAE

CAS2746391-62-6

research compound

ReferenceSame Category

(2E)-3-[1-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-cyano-2-propenoic acid

CAS2260696-63-5

research compound

ReferenceSame Category

5-bromo-2,3-dihydro-1H-inden-4-amine

CAS2260959-47-3

research compound

ReferenceSame Category

5-Chloronicotinic acid

CAS22620-27-5

research compound

ReferenceSame Category

4-Cyanobutylzinc bromide solution

CAS226570-68-9

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2,5-dioxopyrrolidin-1-yl) 6-[[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexanoate

InChIKey

IOJRSUDQDOZEEX-SBEKVBMRSA-N

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)OCC3=CC=C(C=C3)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)CCCCC(=O)ON4C(=O)CCC4=O

Synonyms (1)
  • SC-VC-PAB-MMAE

Sourcing SC-VC-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→